Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Innate Pharma

Start price
Target price
Perf. (%)
€3.51
01.02.22
€4.15
01.02.23
-7.69%
10.02.22

Could be worthwhile Investment >10% per year
buy
LVMH Moët Hennessy Louis Vuitton S.A.

Start price
Target price
Perf. (%)
€681.60
26.01.22
€750.00
26.01.23
4.53%
05.02.22

Could be worthwhile Investment >10% per year
High dividend yield expected
Differentiated customer and product portfolio
Well known brand
buy
Visiomed Group

Start price
Target price
Perf. (%)
€0.17
24.01.22
-
24.01.23
116.40%
25.01.23

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€15.90
23.01.22
-
23.01.23
-5.47%
06.02.22

Could be very worthwhile Investment >20% year
buy
Pierre & Vacances S.A.

Start price
Target price
Perf. (%)
€7.06
22.01.22
-
22.01.23
-88.74%
23.09.22

Could be worthwhile Investment >10% per year
buy
A.S.T. Groupe S.A.

Start price
Target price
Perf. (%)
€5.84
18.01.22
€8.00
18.01.23
-52.74%
19.01.23

Could be worthwhile Investment >10% per year
buy
LVMH Moët Hennessy Louis Vuitton S.A.

Start price
Target price
Perf. (%)
€714.90
11.01.22
€800.00
11.01.23
6.11%
11.01.23

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
LVMH Moët Hennessy Louis Vuitton S.A.

Start price
Target price
Perf. (%)
€674.20
11.01.22
€800.00
-
11.01.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.12
10.01.22
-
10.01.23
-14.85%
01.02.22

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€19.03
04.01.22
-
04.01.23
-7.46%
07.01.22

Risky Investment
Edap Tms S.A. ADR

Start price
Target price
Perf. (%)
€5.00
03.01.22
-
03.01.23
27.00%
15.05.22

Probably not worthwhile Investment
buy
Quantum Genomics S.A.

Start price
Target price
Perf. (%)
€4.32
31.12.21
€5.00
31.12.22
-97.78%
01.01.23

Could be worthwhile Investment >10% per year
buy
Veolia Environnement S.A.

Start price
Target price
Perf. (%)
€32.66
29.12.21
-
29.12.22
-25.96%
30.12.22

buy
AXA S.A.

Start price
Target price
Perf. (%)
€26.14
27.12.21
-
27.12.25
28.56%
11.03.24

Could be worthwhile Investment >10% per year
buy
Eurobio scientific

Start price
Target price
Perf. (%)
€28.54
26.12.21
-
26.12.22
-32.45%
14.03.22

Could be worthwhile Investment >10% per year
buy
Euromedis Groupe

Start price
Target price
Perf. (%)
€10.64
24.12.21
-
24.12.22
-57.99%
25.12.22

Could be worthwhile Investment >10% per year
buy
Orange S.A.

Start price
Target price
Perf. (%)
€9.23
16.12.21
€11.20
16.12.22
18.01%
17.02.22

Known brand
Top 10 in its market
Growths slower than the competition
Revenue decline/stagnation expected
buy
Valneva SE

Start price
Target price
Perf. (%)
€24.64
16.12.21
€33.00
31.12.23
-67.02%
07.09.22

Could be very worthwhile Investment >20% year
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€85.57
14.12.21
€124.00
14.12.22
5.18%
15.12.22

Could be worthwhile Investment >10% per year
buy
Arkema S.A.

Start price
Target price
Perf. (%)
€118.15
13.12.21
€125.00
13.12.22
-26.79%
14.12.22

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
12.12.21
-
12.12.22
8.73%
25.12.21

Could be very worthwhile Investment >20% year
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
11.12.21
€30.00
11.12.22
8.73%
25.12.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
buy
Faurecia S.A.

Start price
Target price
Perf. (%)
€39.97
11.12.21
€43.00
11.12.22
-64.71%
12.12.22

Could be worthwhile Investment >10% per year
buy
Oncodesign S.A.

Start price
Target price
Perf. (%)
€8.61
08.12.21
€10.00
08.12.22
65.85%
09.12.22

Could be worthwhile Investment >10% per year
buy
Pierre & Vacances S.A.

Start price
Target price
Perf. (%)
€6.78
07.12.21
€10.00
07.12.22
4.13%
22.01.22

Could be worthwhile Investment >10% per year